company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,553000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2919000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3472000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3472000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-82000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3530000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3530000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3530000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-61000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,61000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3530000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,884179.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.99
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,884179.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.99
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,884179.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 16:15:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.99
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,775000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4217000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,20000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4972000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,43000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4929000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4929000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-35000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,3044000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7938000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.98
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.98
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,884179.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 21:08:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.98
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,952000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4571000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5523000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5523000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,70000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5453000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5453000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5453000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5453000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.17
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.17
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,884179.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 06:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.17
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,757000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5220000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5977000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5977000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,59000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-136000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-184000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6161000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6179000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6179000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,856000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7035000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.82
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.82
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,884179.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.82
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1706000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5218000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6924000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6924000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,59000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-183000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-234000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7158000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7162000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7162000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-7162000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11939866.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11939866.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11939866.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 16:15:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2024000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4981000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7005000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7005000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6984000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18511889.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,2014-08-06 21:08:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2815000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5316000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8131000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8131000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,271000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-235000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8366000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8358000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8358000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-8358000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20752895.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20752895.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20752895.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,2014-11-12 06:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3797000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7161000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10958000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10958000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,411000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-358000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11316000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-25000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11341000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11341000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,15520000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26861000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1200000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-22.38
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1200000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-22.38
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1240240.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-22.38
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4779000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11518000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16297000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16297000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,510000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-470000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23600000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23600000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23667800.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2015-05-14 19:48:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3493000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9501000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3081000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16075000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16075000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,445000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-431000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16506000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-19000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16525000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16525000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16525000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23906032.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,2015-08-11 16:47:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2533000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,738000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1781000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5052000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5052000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1347000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1341000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6393000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6396000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6396000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6396000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23700000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23700000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23915361.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,2015-11-09 16:57:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1630000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,202000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2925000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4757000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4757000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4747000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1600000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.97
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1600000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.97
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1590211.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.97
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3833000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4845000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8678000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8678000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,685000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-685000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9363000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-385000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9748000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9748000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9748000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.42
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,900000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.42
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,935650.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.42
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3522000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7464000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10986000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10986000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,363000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-253000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.34
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.34
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8360539.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.34
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2946000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8131000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11077000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11077000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,378000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-265000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11342000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,196000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11146000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11146000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11146000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.33
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.33
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8367030.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,2018-08-10 07:31:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.33
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2727000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6145000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8872000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8872000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,388000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,98000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-290000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9162000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8300000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.1
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8300000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8372934.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:16:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.1
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2806000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7779000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10585000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10585000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,395000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,89000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-306000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10891000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10893000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10893000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10893000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8700000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.25
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8700000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.25
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8727935.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.25
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2994000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5512000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8506000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8506000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,398000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,94000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-304000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8810000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8831000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8831000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8831000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.84
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.84
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10529350.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.84
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3237000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6372000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9609000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9609000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,495000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-306000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12100000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12100000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12045355.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 16:31:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3643000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13196000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16839000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16839000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,681000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,371000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-310000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17149000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17144000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17144000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17144000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14255843.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.2
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14255843.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.2
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14255843.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:21:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.2
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4082000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12011000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16093000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16093000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,755000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,343000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-412000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16505000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16501000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16501000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16501000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13600000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.98
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13600000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.98
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13634152.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.98
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4057000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12868000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16925000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16925000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,765000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,511000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-254000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17179000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19100000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19100000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19168448.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4225000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12936000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17161000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17161000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,869000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,502000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-367000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17528000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17527000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17527000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17527000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23400000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23408652.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 16:31:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4247000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14059000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18306000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18306000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,884000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,585000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-299000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18605000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24437451.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24437451.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:21:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4584000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11928000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16512000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16512000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,888000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,475000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-413000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16925000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16920000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16920000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16920000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22800000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.67
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22800000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.67
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22785611.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.67
